Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer

This publication has 10 references indexed in Scilit:

• A phase II study of high dose epirubicin in unresectable non small cell lung cancer
  British Journal of Cancer, 1992
• Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer.
  Journal of Clinical Oncology, 1992
• Fractionated high doses (HD) of epirubicin (E) in adenocarcinoma of the lung (ADL)
  Lung Cancer, 1991
• Activity of high-dose epirubicin in advanced non-small cell lung cancer
  European Journal of Cancer and Clinical Oncology, 1991
• Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
  New England Journal of Medicine, 1991
• A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung Cancer
  American Journal of Clinical Oncology, 1991
• Phase II study of high-dose epirubicin in non-small cell lung cancer
  European Journal of Cancer and Clinical Oncology, 1990
• Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung
  European Journal of Cancer and Clinical Oncology, 1984
• 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data
  Cancer Treatment Reviews, 1983
• Reporting results of cancer treatment
  Cancer, 1981